Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

First lab-made vaccine for Barber’s Pole worm developed
The vaccine trained the sheep's immune system to recognise the parasite.
Previous vaccines involved harvesting worms from slaughtered sheep.

Researchers have developed the first laboratory-made vaccine to protect livestock from Barber’s Pole worm.

The vaccine was produced using a new technique, utilising insect cells to replicate proteins normally found in the parasite.

Barber’s Pole worm is a gastrointestinal parasite, commonly found in sheep and goats. The worm attaches to the animal’s stomach to feed on its blood, resulting in severe anaemia, swelling and, in some cases, death.

The parasite is a significant contributor to livestock disease and economic loss for farmers worldwide.

However, parasite treatment and disease control are becoming more difficult to manage. The parasite has developed a resistance to many previously used treatments.

Prior to this study, the only available vaccine was developed by harvesting the worm from stomachs of slaughtered sheep. This was time-consuming, and also posed ethical issues.

Researchers from the Royal Veterinary College (RVC), in collaboration with the University of Veterinary Medicine and the University of Natural Resources and Life Sciences (both Vienna) have now produced the first lab-made vaccine to tackle Barber’s Pole worm.

For their first study, they developed a new technique, making use of insect cells which generate protective proteins which are normally found in the worm. The proteins then act as antigens, which can support the animal host’s immune response.

A second study then tested the efficacy of the new vaccine on potential host animals.

When given to sheep, the vaccine was found to train their immune system to recognise the parasite and create antibodies. It not only limited the ability of the parasite to establish in the sheep, but also reduced the amount of eggs shed by the parasite.

Researchers hope that their findings could lead to vaccines being produced with animals being slaughtered. The vaccine can also be produced faster, is more reliable, more humane and contributes to global efforts to manage livestock parasites.

It is also believed the new vaccine could reduce the use of chemical wormers, the efficacy of which has been impacted by growing drug resistance.

Dick Werling, professor of molecular immunology at the RVC, said: “This research shows that is indeed possible to create vaccines incorporating “foreign” sugars.

“This is an area my group has been working on for several years, and I am really pleased that we were asked to contribute with our knowledge to this ground-breaking work.”

The full study can be found in the journal npj Vaccines.

Image © Shutterstock

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.